Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine

M. A. Zawaideh, Burris R Duncan, M. W. Joseph, M. P. Dixit

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We report an 11-year-old boy with hypertension and chronic intestinal pseudo-obstruction, which renders him totally dependent on parenteral nutrition and prevents the use of oral medications. Here we report the feasibility of utilizing chronic IV enalaprilat and transdermal clonidine on a chronic basis to control hypertension. Over the last 10 months, the patient's hypertension has been well controlled by 1.25 mg IV enalaprilat every 8 h and a 0.2-mg clonidine patch every 6 days, with no apparent side-effects. There are no reports of IV enalaprilat usage exceeding 3 weeks' duration. Therefore we believe that it is possible to effect reasonable management of chronic hypertension with the use of chronic IV enalaprilat and transdermal clonidine therapy.

Original languageEnglish (US)
Pages (from-to)85-86
Number of pages2
JournalPediatric Nephrology
Volume16
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Enalaprilat
Clonidine
Hypertension
Intestinal Pseudo-Obstruction
Parenteral Nutrition
Therapeutics

Keywords

  • Angiotensin converting enzyme inhibitor
  • Chronic intestinal pseudo-obstruction
  • Chronic treatment
  • Enalaprilat
  • Hypertension
  • Intravenous route

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine. / Zawaideh, M. A.; Duncan, Burris R; Joseph, M. W.; Dixit, M. P.

In: Pediatric Nephrology, Vol. 16, No. 1, 2001, p. 85-86.

Research output: Contribution to journalArticle

Zawaideh, M. A. ; Duncan, Burris R ; Joseph, M. W. ; Dixit, M. P. / Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine. In: Pediatric Nephrology. 2001 ; Vol. 16, No. 1. pp. 85-86.
@article{c35ec9f1858d4ad192b7578322660505,
title = "Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine",
abstract = "We report an 11-year-old boy with hypertension and chronic intestinal pseudo-obstruction, which renders him totally dependent on parenteral nutrition and prevents the use of oral medications. Here we report the feasibility of utilizing chronic IV enalaprilat and transdermal clonidine on a chronic basis to control hypertension. Over the last 10 months, the patient's hypertension has been well controlled by 1.25 mg IV enalaprilat every 8 h and a 0.2-mg clonidine patch every 6 days, with no apparent side-effects. There are no reports of IV enalaprilat usage exceeding 3 weeks' duration. Therefore we believe that it is possible to effect reasonable management of chronic hypertension with the use of chronic IV enalaprilat and transdermal clonidine therapy.",
keywords = "Angiotensin converting enzyme inhibitor, Chronic intestinal pseudo-obstruction, Chronic treatment, Enalaprilat, Hypertension, Intravenous route",
author = "Zawaideh, {M. A.} and Duncan, {Burris R} and Joseph, {M. W.} and Dixit, {M. P.}",
year = "2001",
doi = "10.1007/s004670000483",
language = "English (US)",
volume = "16",
pages = "85--86",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine

AU - Zawaideh, M. A.

AU - Duncan, Burris R

AU - Joseph, M. W.

AU - Dixit, M. P.

PY - 2001

Y1 - 2001

N2 - We report an 11-year-old boy with hypertension and chronic intestinal pseudo-obstruction, which renders him totally dependent on parenteral nutrition and prevents the use of oral medications. Here we report the feasibility of utilizing chronic IV enalaprilat and transdermal clonidine on a chronic basis to control hypertension. Over the last 10 months, the patient's hypertension has been well controlled by 1.25 mg IV enalaprilat every 8 h and a 0.2-mg clonidine patch every 6 days, with no apparent side-effects. There are no reports of IV enalaprilat usage exceeding 3 weeks' duration. Therefore we believe that it is possible to effect reasonable management of chronic hypertension with the use of chronic IV enalaprilat and transdermal clonidine therapy.

AB - We report an 11-year-old boy with hypertension and chronic intestinal pseudo-obstruction, which renders him totally dependent on parenteral nutrition and prevents the use of oral medications. Here we report the feasibility of utilizing chronic IV enalaprilat and transdermal clonidine on a chronic basis to control hypertension. Over the last 10 months, the patient's hypertension has been well controlled by 1.25 mg IV enalaprilat every 8 h and a 0.2-mg clonidine patch every 6 days, with no apparent side-effects. There are no reports of IV enalaprilat usage exceeding 3 weeks' duration. Therefore we believe that it is possible to effect reasonable management of chronic hypertension with the use of chronic IV enalaprilat and transdermal clonidine therapy.

KW - Angiotensin converting enzyme inhibitor

KW - Chronic intestinal pseudo-obstruction

KW - Chronic treatment

KW - Enalaprilat

KW - Hypertension

KW - Intravenous route

UR - http://www.scopus.com/inward/record.url?scp=0035144695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035144695&partnerID=8YFLogxK

U2 - 10.1007/s004670000483

DO - 10.1007/s004670000483

M3 - Article

C2 - 11198612

AN - SCOPUS:0035144695

VL - 16

SP - 85

EP - 86

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 1

ER -